Published in J Bone Joint Surg Br on September 01, 2012
Bilateral fibular graft: biological reconstruction after resection of primary malignant bone tumors of the lower limb. Sarcoma (2013) 0.86
Autoclaved tumor bone for skeletal reconstruction in paediatric patients: a low cost alternative in developing countries. Biomed Res Int (2013) 0.81
The clinical outcomes of extracorporeal irradiated and re-implanted cemented autologous bone graft of femoral diaphysis after tumour resection. Int Orthop (2012) 0.75
[Extracorporeal irradiation : Reimplantation of bone segments in the treatment of malignant bone tumours]. Orthopade (2017) 0.75
Understanding the potentiality of accelerator based-boron neutron capture therapy for osteosarcoma: dosimetry assessment based on the reported clinical experience. Radiat Oncol (2017) 0.75
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet (2001) 5.75
The incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15-year prospective survey. J Bone Joint Surg Br (2006) 4.36
Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg (2001) 2.94
Paradoxical effects of thought suppression. J Pers Soc Psychol (1987) 2.68
Designer hips. BMJ (1993) 2.65
Does curettage without adjuvant therapy provide low recurrence rates in giant-cell tumors of bone? Clin Orthop Relat Res (2005) 2.51
Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet (1997) 2.33
Aseptic loosening in cemented custom-made prosthetic replacements for bone tumours of the lower limb. J Bone Joint Surg Br (1996) 2.32
Treatment for children with brain tumours. BMJ (1995) 2.01
Risk factors for survival and local control in chondrosarcoma of bone. J Bone Joint Surg Br (2002) 1.89
Endoprosthetic replacement of the distal femur for bone tumours: long-term results. J Bone Joint Surg Br (2007) 1.88
Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer. Br J Cancer (2007) 1.84
Endoprosthetic replacement of the proximal tibia. J Bone Joint Surg Br (1999) 1.82
The outcome of perioperative wound infection after total hip and knee arthroplasty. Int Orthop (2002) 1.82
A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup. J Clin Oncol (1992) 1.79
Periprosthetic infection in patients treated for an orthopaedic oncological condition. J Bone Joint Surg Am (2005) 1.77
Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study. J Clin Oncol (1998) 1.66
Chondroblastoma of bone: long-term results and functional outcome after intralesional curettage. J Bone Joint Surg Br (2005) 1.58
Endoprosthetic reconstruction for the treatment of musculoskeletal tumors of the appendicular skeleton and pelvis. J Bone Joint Surg Am (2008) 1.55
Endoprosthetic replacement for primary malignant tumors of the proximal femur. Clin Orthop Relat Res (1999) 1.50
Prosthetic replacement of the distal femur for primary bone tumours. J Bone Joint Surg Br (1991) 1.49
The incidence and significance of fluid-fluid levels on computed tomography of osseous lesions. Br J Radiol (1992) 1.49
Hindquarter amputation: is it still needed and what are the outcomes? Bone Joint J (2013) 1.48
Prognostic factors in localized extremity osteosarcoma: a systematic review. Eur J Surg Oncol (2009) 1.43
Modular endoprosthetic replacement for tumours of the proximal femur. J Bone Joint Surg Br (2009) 1.43
Reconstruction of the hemipelvis after the excision of malignant tumours. Complications and functional outcome of prostheses. J Bone Joint Surg Br (1997) 1.41
Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients. Eur J Cancer (2002) 1.41
Management of malignant phaeochromocytoma: a retrospective review of the use of MIBG and chemotherapy in the West Midlands. Clin Oncol (R Coll Radiol) (2001) 1.38
Clinical features of soft tissue sarcomas. Ann R Coll Surg Engl (2001) 1.37
Early distal femoral endoprosthetic survival: cemented stems versus the Compress implant. Int Orthop (2006) 1.33
The effect of an unplanned excision of a soft-tissue sarcoma on prognosis. J Bone Joint Surg Br (2008) 1.32
The surgical treatment and outcome of pathological fractures in localised osteosarcoma. J Bone Joint Surg Br (1996) 1.31
The 'penumbra sign' on T1-weighted MR imaging in subacute osteomyelitis: frequency, cause and significance. Clin Radiol (1998) 1.29
The outcome and functional results of diaphyseal endoprostheses after tumour excision. J Bone Joint Surg Br (1996) 1.28
Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials. Ann Oncol (2011) 1.28
Can computer navigation-assisted surgery reduce the risk of an intralesional margin and reduce the rate of local recurrence in patients with a tumour of the pelvis or sacrum? Bone Joint J (2013) 1.27
Differential diagnosis of tumours and tumour-like lesions of the infrapatellar (Hoffa's) fat pad: pictorial review with an emphasis on MR imaging. Eur Radiol (2004) 1.26
Peri-acetabular resection and endoprosthetic reconstruction for tumours of the acetabulum. J Bone Joint Surg Br (2008) 1.25
Delays in referral of soft tissue sarcomas. Sarcoma (2008) 1.24
Enhanced cell killing in lewis lung carcinoma and a human pancreatic-carcinoma xenograft by the combination of cytotoxic drugs and misonidazole. Br J Cancer (1981) 1.23
Post operative infection and increased survival in osteosarcoma patients: are they associated? Ann Surg Oncol (2007) 1.23
Do pathological fractures influence survival and local recurrence rate in bony sarcomas? Eur J Cancer (2007) 1.22
The effect of local recurrence on survival in resected osteosarcoma. Eur J Cancer (2001) 1.21
A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer. Br J Cancer (2004) 1.21
The long-term results of endoprosthetic replacement of the proximal tibia for bone tumours. J Bone Joint Surg Br (2007) 1.20
Experience in the treatment of dedifferentiated chondrosarcoma. J Bone Joint Surg Br (2000) 1.19
Upper eyelid gold weight implantation in the Asian patient with facial paralysis. Plast Reconstr Surg (2000) 1.17
Reexamination of series relationships of South American wild potatoes (Solanaceae: Solanum sect. Petota): evidence from chloroplast DNA restriction site variation. Am J Bot (1997) 1.17
Encephalopathy associated with ifosphamide/mesna therapy. Lancet (1985) 1.17
The treatment of benign lesions of the proximal femur with non-vascularised autologous fibular strut grafts. J Bone Joint Surg Br (2008) 1.16
The cost-effectiveness of limb salvage for bone tumours. J Bone Joint Surg Br (1997) 1.16
Osteosarcoma of the pelvis. J Bone Joint Surg Br (1999) 1.16